Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.835
+0.085 (4.86%)
Oct 20, 2026, 11:30 AM EDT - Market open
Pulmonx Revenue
Pulmonx had revenue of $22.76M in the quarter ending June 30, 2026, a decrease of -4.62%. This brings the company's total for the last twelve months to $87.44M, down -3.43% year-over-year. In the year 2025, Pulmonx had annual revenue of $90.50M with 8.01% growth. That makes Pulmonx the 23,676th largest company in the world by revenue and 3,380th in the United States.
Revenue (ttm)
$87.44M
Revenue Growth
-3.43%
P/S Ratio
0.86
Revenue / Employee
$295,412
Employees
296
Market Cap
78.81M
Revenue by Geography
- United States 57.02M 63.0%
- Europe, Middle-East and Africa (EMEA) 26.99M 29.8%
- Asia Pacific 6.23M 6.9%
- Other International 260.00K 0.3%
Fiscal year ended Dec 31, 2025 See the full Pulmonx breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 90.50M | 6.71M | 8.01% |
| Dec 31, 2024 | 83.79M | 15.11M | 22.01% |
| Dec 31, 2023 | 68.68M | 15.01M | 27.98% |
| Dec 31, 2022 | 53.66M | 5.25M | 10.84% |
| Dec 31, 2021 | 48.42M | 15.68M | 47.91% |
| Dec 31, 2020 | 32.73M | 138.00K | 0.42% |
| Dec 31, 2019 | 32.60M | 12.59M | 62.94% |
| Dec 31, 2018 | 20.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Outset Medical | 117.80M |
| LENSAR | 60.26M |
| Apyx Medical | 58.42M |
| Myomo | 43.26M |
| electroCore | 36.97M |
| Nyxoah | 24.75M |
| Hyperfine | 16.54M |
| Lucid Diagnostics | 5.45M |
LUNG News
- 6 days ago - Pulmonx to Report Third Quarter 2026 Financial Results on October 27, 2026 - GlobeNewsWire
- 6 weeks ago - Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Pulmonx to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 1 month ago - Pulmonx management to meet virtually with Lake Street - TheFly
- 2 months ago - Pulmonx Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 2 months ago - Pulmonx reports Q2 EPS (24c), consensus (28c) - TheFly
- 2 months ago - Pulmonx backs FY26 revenue view $90M-$92M, consensus $90.77M - TheFly
- 2 months ago - Pulmonx Earnings Call Transcript: Q2 2026 - Transcripts